Global Market for Pain Management Patches

Report Highlights

The global market for pain management patches should grow from $4.2 billion in 2018 to $5.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.5% for the period of 2018-2023.

Report Includes

• 31 data tables and 15 additional tables
• An overview of the global market for pain management drugs used in the form of patches for immediate relief from any type of pain
• Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Assessment of current market size, market forecast, and main driving forces for the pain relief patches market
• Briefing about antihypertensive drugs, their pathophysiology and pathogenesis and major adverse effects of various antihypertensive drugs
• Information on significant products, issues and trends, market influences, regulatory issues and other information affecting the pain relief patches market
• Profile description of major market players including Endo Pharmaceuticals Inc., GlaxoSmithKline PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi

Report Scope

The current report offers a detailed picture of the pain relief patch market. Opioid and NSAID pain management patches have been analyzed in the report, and patch regulations and demand for addressing different types of pain have been included in the scope of the study. The report excludes drugs used in the treatment of hormonal pain. The market size includes both branded and generic drugs. 

The report highlights the current and future market potential of pain management patches and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key market players.

The report details market shares of pain management patches based on drug, major segment, application and geography. 

Based on drug, the market is segmented into fentanyl patches, buprenorphine, lidocaine, diclofenac, ketoprofen, capsaicin, methyl salicylate, menthol and others (glycol salicylate, tocopherol acetate, camphor, etc.). 

Based on major segment, the market is segmented into over the counter (OTC) and prescription. 

Based on category of pain, the market is segmented into acute pain and chronic pain. 

By geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Spain, Italy, Japan, China, Australia, New Zealand and India are covered in regional segments. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Artificial Intelligence (AI) in Cancer (BIO196B)
• Nutraceuticals: Global Markets (FOD013J)
• Protective Relays and Circuit Breakers: Global Markets (IAS157B)
• Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
• Flow Batteries: Global Markets (FCB055B)